CRISPR paper that sent stocks tumbling is retracted – STAT
STAT |
CRISPR paper that sent stocks tumbling is retracted
STAT scientific paper that purported to lay bare serious flaws in the gene-editing tool known as CRISPR and briefly tanked shares 1 of genome-editing companies has been retracted by its publisher. The paper 2, published last year in Nature Methods, claimed … Science Journal Retracts Paper That Sparked CRISPR PanicGizmodo Crispr’d Food, Coming Soon to a Supermarket Near You | WIREDWIRED You Could Be Eating CRISPR Food in Five Years | Fast Forward | OZYOZY Livemint all 9 news articles » |
FierceBiotech |
Disarming cancer’s defenses to improve immunotherapy
FierceBiotech “Using checkpoint blockade has revolutionized the field of cancer immunotherapy, but it is not enough to simply stop the cancer from evading the immune system, we need to boost the immune system to fight the cancer off. By combining checkpoint blockade … |
|
Solid Recommits to DMD Gene Therapy on Clinical Hold, as Stock Plunge Sparks Lawsuits
Genetic Engineering & Biotechnology News Solid Biosciences restated its commitment to developing its lead candidate, the Duchenne muscular dystrophy (DMD) gene therapy SGT-001, despite the FDA’s full and partial clinical holds on a Phase I/II trial for the treatment. The FDA last month … |